Stockscreener 앱 받기
2.72
3.20%
-0.09
시간 외 거래:
2.77
0.05
+1.84%
전일 마감가:
$2.81
열려 있는:
$2.81
하루 거래량:
1.10M
Relative Volume:
0.30
시가총액:
$583.88M
수익:
$12.87M
순이익/손실:
$-114.34M
주가수익비율:
-3.146
EPS:
-0.8646
순현금흐름:
$-79.23M
1주 성능:
+3.42%
1개월 성능:
+12.40%
6개월 성능:
+55.43%
1년 성능:
+29.52%
1일 변동 폭
$2.70
$2.845
1주일 범위
$2.54
$2.845
52주 변동 폭
$1.05
$3.31
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
명칭
Taysha Gene Therapies Inc
전화
(214) 612-0000
주소
3000 PEGASUS PARK DRIVE, DALLAS
TSHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
2.72 | 729.67M | 12.87M | -114.34M | -79.23M | -0.8646 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | BofA Securities | Buy |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-04-09 | 개시 | Piper Sandler | Overweight |
| 2023-02-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-03-09 | 개시 | Robert W. Baird | Outperform |
| 2022-03-01 | 개시 | Wells Fargo | Overweight |
| 2022-02-18 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | Guggenheim | Buy |
| 2021-07-16 | 개시 | Needham | Buy |
| 2021-06-24 | 개시 | Truist | Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-06-09 | 개시 | Wedbush | Outperform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 재개 | Jefferies | Buy |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-01-05 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-19 | 개시 | Goldman | Buy |
| 2020-10-19 | 개시 | Jefferies | Buy |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
Wells Fargo Remains Bullish on Taysha Gene Therapies (TSHA) - MSN
Earnings Preview: TSHA to Report Financial Results Pre-market on August 12 - 富途牛牛
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12 - The Manila Times
Taysha Gene Therapies to Release Second Quarter 2025 - GlobeNewswire
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance
RSI Crosses Above 30 for Taysha Gene Therapies Inc. — Reversal in SightCommunity Shared Smart Money Signals Show Movement - beatles.ru
What are analysts’ price targets for Taysha Gene Therapies Inc. in the next 12 monthsDiscover undervalued stocks before they soar - Jammu Links News
What are Taysha Gene Therapies Inc. company’s key revenue driversBuild wealth with steady, reliable stocks - Jammu Links News
How many analysts rate Taysha Gene Therapies Inc. as a “Buy”Maximize gains with data-driven stock picks - Jammu Links News
What analysts say about Taysha Gene Therapies Inc. stockSuperior trading gains - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
What is Taysha Gene Therapies Inc. company’s growth strategyTriple returns potential - Jammu Links News
Is Taysha Gene Therapies Inc. stock overvalued or undervaluedUnlock real-time stock alerts for quick profits - Jammu Links News
How does Taysha Gene Therapies Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
What are the latest earnings results for Taysha Gene Therapies Inc.Maximize returns with strategic trading plans - Jammu Links News
What are the technical indicators suggesting about Taysha Gene Therapies Inc.Achieve triple-digit returns with smart investing - Jammu Links News
What makes Taysha Gene Therapies Inc. stock price move sharplyAchieve breakthrough financial growth - jammulinksnews.com
Taysha Gene Therapies Announces New Employee Stock Option Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - MSN
What is the risk reward ratio of investing in Taysha Gene Therapies Inc. stockDaily Trading Opportunities For Fast Growth - Jammu Links News
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Taysha Gene Therapies Offers $236,700 Stock Option Package to Strategic New Hire - Stock Titan
Fibonacci Retracement Aligns with Support in Taysha Gene Therapies Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
BofA Securities Affirms ‘Buy’ Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects - MSN
Needham Maintains a Buy on Taysha Gene Therapies (TSHA), Keeps PT at $8 - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
Will Taysha Gene Therapies Inc. stock benefit from AI tech trendsFree Smart Money Stock Analysis - beatles.ru
How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest
What institutional investors are buying Taysha Gene Therapies Inc. stockExponential return rates - Jammu Links News
Is it the right time to buy Taysha Gene Therapies Inc. stockMaximize your gains with professional insights - Jammu Links News
Why is Taysha Gene Therapies Inc. stock attracting strong analyst attentionCapitalize on fast-moving market trends - Jammu Links News
Certain Options of Taysha Gene Therapies, Inc. are subject to a Lock-Up Agreement Ending on 28-JUL-2025. - MarketScreener
How Taysha Gene Therapies Inc. stock performs during market volatility200 Percent Profit Outlook - metal.it
Taysha Gene Therapies Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Is Taysha Gene Therapies Inc. a good long term investmentLightning-fast growth - PrintWeekIndia
Can Taysha Gene Therapies Inc. stock recover from recent declineConsistently profitable trades - Jammu Links News
Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech
What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional
Taysha Gene Therapies Inc (TSHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):